Circulating Tumor Antigens and their Autoantibody Reactivity as Cancer Markers

3,920 views

|

May 2, 2013

  • Share
  • The dynamic shedding of proteins and antigens from tumor cells offers an opportunity to develop cancer markers based on the detection of such proteins and the immune response they engender in the form of autoantibodies.

    BiopharmaGenomicsImmunologyMicrofluidics

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.